Fiscal Year 2015

Papers

  1. Hatta T, Narita K, Yanagihara K, Ishiguro H, Murayama T , Yokode M. Measuring motivation for medical treatment: confirming the factor structure of the Achievement Motivation Index for Medical Treatment (AMI-MeT). BMC Medical Informatics and Decision Making. 2016; 16: 22. DOI 10.1186/s12911-016-0260-0.
  2. Fujita MHatta T, Reina O, Akabayashi A. The current status of clinics providing private practice cell therapy in Japan. Regenerative Medicine. 2016; 11(1): 23-32.
    DOI: 10.2217/rme.15.64.
  3. Ikka T, Fujita MYashiro Y, Ikegaya H. Recent Court Ruling in Japan Exemplifies Another Layer of Regulation for Regenerative Therapy. Cell Stem Cell. 2015; 17(5): 507-508. DOI: 10.1016/j.stem.2015.10.008.
  4. Takahashi S, Fujita M, Akabayashi A. “Mottainai” embryos and the earthquake. J Clin res Bioethics. (2015) 7: 258. DOI: 10.4172/2155-9627.1000258.
  5. Sengoku S, Sakurai M, Yashiro Y.Japan’s regulatory framework: seeking to provide impetus to the commercialization of regenerative medicine products. Cell Gene Therapy Insights. 2015; 1(1), 83-92. DOI: 10.18609.cgti.2015.008.

Reports

  1. Savulescu J and Fujita M eds. Uehiro Carnegie Oxford Conference 2014 ‘ETHICS FOR THE FUTURE OF iPS / STEM CELLS’. 2016.
  2. Sawai T (Savulescu J and Fujita M eds.). Priority Setting in Research of Induced Pluripotent Stem Cells. Uehiro Carnegie Oxford Conference 2014 ’ETHICS FOR THE FUTURE OF iPS / STEM CELLS’. 2016: 17-28.
  3. Yashiro Y (Savulescu J and Fujita M eds.). Regenerative Medicine in Popular Culture. Uehiro Carnegie Oxford Conference 2014 ‘ETHICS FOR THE FUTURE OF iPS / STEM CELLS’. 2016: 91-95.
  4. Fujita MHatta T (Savulescu J and Fujita M eds.). The Current State of Experimental Cell Therapy and New Laws in Japan. Uehiro Carnegie Oxford Conference 2014 ‘ETHICS FOR THE FUTURE OF iPS / STEM CELLS’. 2016: 107-116.
  5. Suzuki M, Sato K (Savulescu J and Fujita M eds.). Developing a Program to Foster Professionalism for Stem Cell Research. Uehiro Carnegie Oxford Conference 2014 ‘ETHICS FOR THE FUTURE OF iPS / STEM CELLS’. 2016: 153-159.